Harvest Fund Management Co., Ltd - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Harvest Fund Management Co., Ltd ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$51
-75.1%
574
-76.2%
0.01%
-78.0%
Q2 2023$205
+83.0%
2,411
+78.7%
0.04%
+64.0%
Q1 2023$112
+202.7%
1,349
+185.8%
0.02%
+150.0%
Q4 2022$37
-99.9%
4720.0%0.01%0.0%
Q3 2022$35,000
+191.7%
472
+84.4%
0.01%
+900.0%
Q4 2019$12,000
-92.2%
256
-78.9%
0.00%
-95.0%
Q3 2019$153,000
+264.3%
1,213
+247.6%
0.02%
+300.0%
Q2 2019$42,000
-85.7%
349
-88.1%
0.01%
-91.8%
Q4 2018$293,000
-48.6%
2,929
-41.1%
0.06%
-37.8%
Q3 2018$570,0004,9750.10%
Other shareholders
HAEMONETICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders